Comparing two blood thinners during heart procedures after clot-busting treatment
Treatments studied
Part of Heart & circulation clinical trials.
This study compares two blood-thinning medicines used during a heart procedure (PCI) after you've already received clot-busting drugs. The goal is to see which one helps prevent more blockages and complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack (STEMI) and received clot-busting medicine within 12 hours of symptoms.
- You are scheduled for a procedure to open the blocked artery (PCI) within 24 hours of symptom onset.
- You are taking two blood thinners: aspirin plus either clopidogrel or ticagrelor.
- You are not in cardiogenic shock (extremely low blood pressure) and have no severe heart damage like a ruptured valve.
- You have not had a PCI in the past 30 days and are not allergic to the study medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood thinners, bivalirudin and heparin, given during a heart procedure to open blocked arteries (PCI). It aims to find which one is safer for people at high risk of bleeding.
This study tests whether a blood thinner called bivalirudin, given during a procedure to open blocked heart arteries (PCI), helps blood flow better in the tiny vessels of the heart afterward. It is for people with a recent unstable heart condition and a high-risk plaque seen on a CT scan.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This trial looks at whether using heart imaging (OCT or angiogram) to guide how long you take two blood thinners after a heart attack (STEMI) can be safe and effective. If you qualify, your doctor may be able to reduce your blood thinner use sooner, which could lower bleeding risk while still protecting your heart.
This trial compares two common blood-thinning medications (prasugrel vs ticagrelor) and two treatment durations (short 1–3 months vs standard 12 months) after a heart attack treated with stents. It aims to find the most effective and safest anti-clotting strategy for patients.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.